Since 2014, CBIS has been the interdisciplinary hub for an Institute-wide partnership with the Icahn School of Medicine at Mount Sinai in New York City to transform biomedicine through discovery, development, and training in technology-based medical solutions.
Mount Sinai is a leader in biomedical research and patient care. RPI is a top-tier higher education research center in engineering, life sciences, data and computational sciences, and more.
The partnership accelerates the pace of innovation and entrepreneurship across the health sciences.
The primary goal articulated from the outset of our partnership is to transform biomedicine through technology-based solutions to critical unmet health-care needs. In subsequent years, students and faculty have engaged in multidisciplinary endeavors ranging from academic research and product development to degree programs in bio-entrepreneurship. The affiliation has expanded the research conducted at both institutions in areas such as precision medicine, drug discovery, stem cell biology, robotics and robotic surgery, novel imaging techniques, cellular engineering, and computational neurobiology.
A relatively recent outgrowth of this partnership is that RPI and ISMMS have started the Center for Engineering and Precision Medicine (CEPM). The center is built on the premise that engineering is fundamental to understanding biomedical phenomena and developing the next generation of precision diagnostics and therapeutics. CEPM brings a diverse set of experts together in a single location in New York City to focus on research, education, and entrepreneurial translational science. By co-locating state-of-the-art engineering and medicine, the center is working toward solving society’s most intractable diseases, advancing individualized treatment, and improving quality of life for patients.
